Conjugation of folic acid with poly (NVCL-co-PEGMA)-grafted chitosan as a new doxorubicin delivery system.

This paper aimed to investigate the synthesis of a novel drug delivery system (DDS) to target tumors and implement the controlled release of doxorubicin (DOX). Chitosan was modified with 3-mercaptopropyltrimethoxysilane and subjected to graft polymerization to implement grafting with the biocompatible thermosensitive copolymer of poly (NVCL-co-PEGMA). A folate receptor-targeting agent was obtained by attaching folic acid. The DDS loading capacity for DOX via physisorption was obtained to be 846.45 mg/g. The synthesized DDS showed temperature- and pH-sensitive drug release behavior in vitro. A temperature of 37 °C and a pH of 7.4 hindered the DOX release, whereas a temperature of 40 °C and a pH of 5.5 led to DOX release acceleration. In addition, the release of DOX was found to occur in a Fickian diffusion mechanism. The MTT assay tests indicated that the synthesized DDS was not detectably toxic to cell lines of breast cancer, while the toxicity of the DOX-loaded DDS was found to be substantial. The cell absorption enhancement of folic acid led to higher cytotoxicity of the DOX-loaded DDS than bare DOX. As a result, the proposed DDS could be a promising alternative for the targeted therapy of breast cancer through controlled drug release.

Integration of Porous Nanomaterial-Infused Membrane in UF/FO Membrane Hybrid for Simulated Osmosis Membrane Bioreactor (OsMBR) Process.

This study explored the use of a combination of hydrothermal and sol-gel methods to produce porous titanium dioxide (PTi) powder with a high specific surface area of 112.84 m2/g. The PTi powder was utilized as a filler in the fabrication of ultrafiltration nanocomposite membranes using polysulfone (PSf) as the polymer. The synthesized nanoparticles and membranes were analyzed using various techniques, including BET, TEM, XRD, AFM, FESEM, FTIR, and contact angle measurements. The membrane's performance and antifouling properties were also assessed using bovine serum albumin (BSA) as a simulated wastewater feed solution. Furthermore, the ultrafiltration membranes were tested in the forward osmosis (FO) system using a 0.6-weight-percent solution of poly (sodium 4-styrene sulfonate) as the osmosis solution to evaluate the osmosis membrane bioreactor (OsMBR) process. The results revealed that the incorporation of PTi nanoparticles into the polymer matrix enhanced the hydrophilicity and surface energy of the membrane, resulting in better performance. The optimized membrane containing 1% PTi displayed a water flux of 31.5 L/m2h, compared to the neat membrane water value of 13.7 L/m2h. The membrane also demonstrated excellent antifouling properties, with a flux recovery of 96%. These results highlight the potential of the PTi-infused membrane as a simulated osmosis membrane bioreactor (OsMBR) for wastewater treatment applications.

pH-responsive glycodendrimer as a new active targeting agent for doxorubicin delivery.

The present study synthesized a new kind of pH-responsive active targeting glycodendrimer (ATGD) for doxorubicin delivery to cancerous cells. First, the glycodendrimer was synthesized based on the cultivation of chitosan dendrons on amine-functionalized, silica-grafted cellulose nanocrystals. Afterward, glycodendrimer was conjugated with folic acid to provide a folate receptor-targeting agent. The response surface method was employed to obtain the optimum conditions for the preparation of doxorubicin-loaded ATGD. The effect of doxorubicin/ATGD ratio, temperature, and pH on doxorubicin loading capacity was evaluated, and high loading capacity was achieved under optimized conditions. After determining doxorubicin release pattern at acidic and physiological pH, ATGD cytotoxicity was surveyed by MTT assay. Based on the results, the loading behavior of doxorubicin onto ATGD was in good agreement with monolayer-physisorption, and drug release was Fickian diffusion-controlled. ATGD could release the doxorubicin much more at acidic pH than physiological pH, corresponding to pH-responsive release behavior. Results of MTT assay confirmed the cytotoxicity of doxorubicin-loaded ATGD in cancer cells, while ATGD (without drug) was biocompatible with no tangible toxicity. These results suggested that ATGD has the potential for the treatment of cancer.

Synthesis of thermosensitive magnetic nanocarrier for controlled sorafenib delivery.

Allyl glycidyl ether/N-isopropylacrylamide-grafted magnetic nanoparticles were prepared using silica-coated magnetic nanoparticles as a substrate for radical copolymerization of allyl glycidyl ether and N-isopropylacrylamide. Chitosan was coupled with the prepared nanoparticles by opening the epoxy ring of the allyl glycidyl ether. The thermosensitive magnetic nanocarrier (TSMNC) obtained can be applied as a potent drug carrier. The TSMNC structure was characterized using Fourier transform infrared spectroscopy, X-ray diffraction, thermogravimetric analysis, differential scanning calorimetry, vibrating sample magnetometer, and elemental analysis. Its morphology and size were investigated using field emission scanning electron microscopy, transmission electron microscopy and dynamic light scattering. The feasibility of employing the TSMNC for adsorption and in vitro controlled release of the chemotherapeutic agent sorafenib was tested. The effect of the adsorption parameters of pH, temperature, and loading time of sorafenib onto TSMNC was evaluated. The adsorption data was fitted to the Langmuir and Freundlich isotherms and the relevant parameters derived. The drug release profile indicated that 88% of the adsorbed drug was released within 35h at 45°C and drug release was Fickian diffusion-controlled. The results confirmed that the TSMNC has a high adsorption capacity at low temperature and good controlled release in a slow rate at a high temperature and could be developed for further application as a drug nanocarrier.